ClinicalTrials.Veeva

Menu

Influence of Strength Training and Protein Supplementation on Fitness of Institutionalized Elderly

U

University of Vienna

Status

Unknown

Conditions

Aging

Treatments

Behavioral: Cognitive Training
Dietary Supplement: FortiFit
Behavioral: Strength Training

Study type

Interventional

Funder types

Other

Identifiers

NCT01775111
ActiveAgeing

Details and patient eligibility

About

The aim of this randomized, observer-blind, controlled intervention study with parallel groups is to study the effect of strength training (2x/week for 6 months) with and without additional dietary supplementation (protein-enriched) on muscle strength, function and mass, oxidative stress parameters and the immune system in elderly institutionalized persons.

The participants (n = 120) are recruited from Viennese senior residencies (Kuratorium Wiener Pensionistenwohnheime). After a pre-participation screening participants will be distributed randomly but stratified by sex and age to one of the 3 intervention groups (cognitive training, strength training, strength training + supplement).

Study participants are eligible if they are male or female with an age over 65 years and if their cognitive status as well as their physical fitness level allows to participate at the strength training sessions. Exclusion criteria comprise chronic diseases which contraindicate the medical training therapy, serious cardiovascular disease, diabetic retinopathy and manifest osteoporosis, medication with anticoagulants or cortisone drugs and also regular strength training during the last six months.

Primary outcome measure is the change in isokinetic torque of knee extensors. Secondary outcome measures comprise anthropometric data, functional performance tests, immunological and oxidative stress parameters. The change in muscle signaling pathways will be assessed from muscle biopsies.

Enrollment

120 estimated patients

Sex

All

Ages

65+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adequate mental condition in order to follow the instructions and to perform the resistance exercise independently (Mini-Mental-State >23)
  • Ability to walk 10 meters independently (without orthopaedic devices)
  • 4 or more points at the Short Physical Performance Battery

Exclusion criteria

  • Chronic diseases, which contraindicate a medical training therapy
  • Serious cardiovascular diseases (congestive chronic heart failure, severe or symptomatic aortic stenosis, unstable angina pectoris, untreated arterial hypertension, cardiac arrhythmias)
  • Diabetic retinopathy
  • Manifest osteoporosis
  • Regular use of cortisone-containing drugs
  • Regular strength training (> 1x / week) in the last 6 months before inclusion

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

120 participants in 3 patient groups

Cognitive Training
Sham Comparator group
Description:
Cognitive Training (riddles, skill games, ...) is performed twice a week in small groups
Treatment:
Behavioral: Cognitive Training
Strength Training
Experimental group
Description:
Progressive strength training is applied, meaning that the intensity is adjusted continuously in order to obtain a sufficient training stimulus. Exercises are chosen to involve the major muscle groups and are performed by using the own body weight or elastic bands.
Treatment:
Behavioral: Strength Training
Strength Training and Supplement
Experimental group
Description:
In addition to strength training as described above, participants receive a water-soluble dietary supplement 9x/week (FortiFit, Nutricia) consisting of 20.7 g of protein (56 En%, 19.7 g whey protein, 3 g leucine,\> 10 g essential amino acids), 9.3 g carbohydrates (25 En%, 0.8 BE), 3.0 g fat (18 En%), 1.2 g fiber (2 En%), 800 IU (20μg) of vitamin D, 250mg calcium, vitamins B6 and B12, folic acid and magnesium.
Treatment:
Dietary Supplement: FortiFit
Behavioral: Strength Training

Trial contacts and locations

1

Loading...

Central trial contact

Michael Quittan, Prim. Univ.Prof. Dr.; Barbara Wessner, Ass.-Prof. DI Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems